- Home
- PPBI vs ARWR Comparison
PPBI vs ARWR Comparison
Compare PPBI & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBI
- ARWR
- Stock Information
- Founded
- PPBI 1983
- ARWR 2003
- Country
- PPBI United States
- ARWR United States
- Employees
- PPBI N/A
- ARWR N/A
- Industry
- PPBI Major Banks
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- PPBI Finance
- ARWR Health Care
- Exchange
- PPBI Nasdaq
- ARWR Nasdaq
- Market Cap
- PPBI 2.2B
- ARWR 1.8B
- IPO Year
- PPBI 1997
- ARWR 1993
- Fundamental
- Price
- PPBI $22.57
- ARWR $15.74
- Analyst Decision
- PPBI Buy
- ARWR Buy
- Analyst Count
- PPBI 4
- ARWR 8
- Target Price
- PPBI $27.25
- ARWR $43.71
- AVG Volume (30 Days)
- PPBI 1.2M
- ARWR 2.1M
- Earning Date
- PPBI 07-24-2025
- ARWR 08-07-2025
- Dividend Yield
- PPBI 5.96%
- ARWR N/A
- EPS Growth
- PPBI N/A
- ARWR N/A
- EPS
- PPBI 1.43
- ARWR N/A
- Revenue
- PPBI $584,278,000.00
- ARWR $545,209,000.00
- Revenue This Year
- PPBI N/A
- ARWR $22,384.93
- Revenue Next Year
- PPBI $6.74
- ARWR N/A
- P/E Ratio
- PPBI $15.55
- ARWR N/A
- Revenue Growth
- PPBI 48.04
- ARWR 1436.97
- 52 Week Low
- PPBI $18.06
- ARWR $9.57
- 52 Week High
- PPBI $30.28
- ARWR $29.86
- Technical
- Relative Strength Index (RSI)
- PPBI 56.38
- ARWR 44.97
- Support Level
- PPBI $21.15
- ARWR $14.30
- Resistance Level
- PPBI $22.41
- ARWR $16.62
- Average True Range (ATR)
- PPBI 0.60
- ARWR 1.17
- MACD
- PPBI -0.06
- ARWR -0.30
- Stochastic Oscillator
- PPBI 70.65
- ARWR 28.66
About PPBI Pacific Premier Bancorp Inc
Pacific Premier Bancorp Inc through its subsidiaries, provides banking products and services. It offers cash management, electronic banking services, credit facilities, and retirement accounts, among others.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.